Global Community
Our community narratives are driven by numbers and valuation.
Community Investing Ideas
Global Weekly Picks
The Concentration Trap: Why the S&P 500 Is No Longer a 'Safe' Diversifier
For decades, financial advisors told clients to "buy SPY for diversification." Today, that advice is mathematically questionable. As of February 2026, the Top 10 Holdings (led by NVIDIA, Microsoft, and Apple) account for a record 41.2% of the entire index.Read more
Transformational Merger
Following the massive acquisition of HMY in early 2025, ITAB is no longer just a Nordic player but a dominant European force in retail solutions However, as of early 2026, the market is currently expressing skepticism about the speed of this integration, as reflected in the recent share price volatility 1. The Narrative: The Integrated Retail Architect The Story: ITABs narrative has shifted from being a manufacturer of "shelves and checkouts" to a Solution Provider.Read more
Beyond the "Value Trap"—Defending the $50 Intrinsic Floor
The 2026 reality for Gold Fields is a story of Multiple Expansion driven by a structural scarcity of high-quality gold assets. At a trading price of $51.00, GFI has finally broken free from the "emerging market discount" that historically tethered it to the low teens.Read more
Freehold: Offers a fantastic growth-income intersection up to $50 WTI. Below $50 WTI, it may offer historic opportunities in terms of ROI.
Operational Depth and Strategic Pivot Analysis 1. Business Model Mechanics: Inflation-Resilient Cash Flow Freehold Royalties' business model differs from traditional Exploration and Production (E&P) companies with a fundamental structural advantage: The company does not bear any of the costs of drilling, completion, operation, or environmental rehabilitation on its land.Read more
UnitedHealth Group's Future Revenue Grows by 3.59%: What Will It Mean?
UnitedHealth (UNH): A Data Giant Hidden in an Insurer's Crisis Investment Narrative – February 2026 Price Target (12m): $395.00 (+35% upside) Rating: Strong Buy (Contrarian) 1. The Core Thesis: The "Optum" Mispricing The market is currently valuing UnitedHealth through the narrow lens of a traditional insurer struggling with Medicare Advantage (MA) rate cuts and CMS regulatory headwinds for 2027.Read more
Why EnSilica is Worth Possibly 13x its Current Price
Okay, so you are probably thinking… yeah right, here’s that degenerate Double Bubbler banging on about that penny stock again. Well take a brief moment and read the following to see why my opinion is not so outlandish.Read more
Investment Thesis: Olvi Oyj (OLVAS)
Date: February 17, 2026 Recommendation: Long / Accumulate 1. Executive Summary: The Geopolitical Arbitrage Olvi Oyj represents a rare asymmetric opportunity in the European consumer staples sector.Read more
Norwegian Air Shuttle's revenue will grow by 73.56% and profitability will soar
I have held the stock of this company for 5 years My target is 200 NOK. $NAS.OL (Norwegian Air Shuttle Q2 figures: Profitability soars, inaugural dividend declared Norwegian announced its first dividend since restructuring, with NOK 0.90 per share (approval 10July2025, ex-dividend date 12August 2025, payment date 20August 2025 ) The airline reported a profit before tax of NOK 1,055 million, a significant improvement from the NOK -611 million EBIT reported in Q1.Read more
Sogeclair's Outlook Will See a 18x Future PE in Five Years
Sogeclair est un acteur de l'ingénierie de haute technologie (aéronautique, spatial, transport). C'est un dossier typique de "Small Cap" industrielle.Read more
